TFS
AST

TrustCore Financial Services’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

TrustCore Financial Services’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6
Closed – – 880
2018
Q4 		$0 Hold
6
– – ﹤0.01% 883
2018
Q3 		$0 Hold
6
– – ﹤0.01% 1053
2018
Q2 		$0 Hold
6
– – ﹤0.01% 1011
2018
Q1 		$0 Hold
6
– – ﹤0.01% 744
2017
Q4 		$0 Buy
+6
New +$15 ﹤0.01% 695

TrustCore Financial Services's AST Position: Q1 2019 in Review

TrustCore Financial Services sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 6 shares.

TrustCore Financial Services first reported a position in AST in Q4 2017 and held it in 5 quarters. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • TrustCore Financial Services reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • TrustCore Financial Services sold 6 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • TrustCore Financial Services first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2017 and held it in 5 quarters.
  • TrustCore Financial Services's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on TrustCore Financial Services's 13F filing for Q1 2019, filed 7 May 2019.